SOLACI Research Registries Continue to Grow

SOLACI Research department put us up to speed on their Research Registry progress during SOLACI-CACI 2024. Similarly, they shared the outcomes of the Latin American Clinical Guidelines carried out together with the Inter American Society of Cardiology: TAVR vs SAVR in Patients with Severe Aortic Stenosis (2021) and PCI vs CABG in Left Main Disease (2023). 

The presentation was held on August 8, 2024 at the Hilton Hotel Convention Center in Buenos Aires, room Buen Ayre C. The aim of this session was to share the Latin American experience with SOLACI Registries in different interventional cardiology scenarios. 

At the start of this session, Dr. Lucio Padilla (ARG) presented data from the Latin American Registry of Coronary Bifurcation Percutaneous Intervention – LATAM Bif -, so far enrolling over 2000 patients. During his presentation, Dr. Padilla, the main registry researcher, analyzed registry patient characteristics, bifurcation types we deal with in Latin America, the different bifurcation PCI strategies in LATAM, and of course the initiative outcomes. 

Padilla-SOLACI-LATAMBIF-registry-FINAL

Dr. Gustavo Pedernera (ARG) followed with progress made on the LATAM SOLACI Peripheral Registry, this year reaching 1760 patients. During his talk, Dr. Pedernera reminded us of the main objectives of this novel research initiative (seeing as there are no other registries on lower limb angioplasty in our region) detailing the main stats and characteristics of data collected so far. Over the end, the Argentinian doctor pointed out that “being able to count on a registry shared with the whole of LATAM, with reliable data, will enable us to know and improve the treatment of peripheral artery disease, reducing amputations and cardiovascular risk.” 

registr-periferic-gustav-pedernera

Next, Dr. Henrique Ribeiro (BRA) presented the TAVR vs SAVR Clinical Guidelines in Patients with Severe Aortic Stenosis, and Dr. Pablo Lamelas (ARG), SOLACI Research Director, shared PCI vs CABG Guidelines in Left Main Disease, both product of the joint effort of SOLACI and the Inter American Society of Cardiology. 

The discussion panel was comprised of reputed medical doctors in the region such as Dr. Guering Eid-Lidt, Ernesto Torresani (ARG), Alfredo Bravo (ARG), Marcelo Halac (ARG), José Abelardo López (VEN) and Jesús García (VEN). In addition, Dr. José Leonidas Alves Jr presented a report on Katana Thrombectomy System cases. 

If you wish to make part of SOLACI Research Registries or should you have any questions, please write to research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Más artículos de este Autor

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...